Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011

Neuro-Oncology

Volumn 15, Issue 6, 2013, Pages 767-774

  Cohen, Michal ^a,b   Bartels, Ute ^a,b   Branson, Helen ^a,b   Kulkarni, Abhaya V ^a,b   Hamilton, Jill ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

craniopharyngioma; hypothalamic obesity; interferon alpha; intracystic chemotherapy; pediatrics

Indexed keywords

BLEOMYCIN; FOLLITROPIN; GROWTH HORMONE; INTERFERON; LUTEINIZING HORMONE;

ADOLESCENT; ARTICLE; ASPIRATION; BODY MASS; BRAIN DECOMPRESSION; BRAIN SURGERY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; FEMALE; FENESTRATION; FOLLOW UP; GROUPS BY AGE; HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; MALE; MEDICAL RECORD REVIEW; OBESITY; OMMAYA RESERVOIR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; QUALITY OF LIFE; SCHOOL CHILD; SURGICAL APPROACH; SURVIVAL RATE; TREND STUDY; TUMOR RECURRENCE;

CRANIOPHARYNGIOMA; HYPOTHALAMIC OBESITY; INTERFERON ALPHA; INTRACYSTIC CHEMOTHERAPY; PEDIATRICS;

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIOPHARYNGIOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MORTALITY; NEOPLASM GRADING; OBESITY; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 84878268025     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not026     Document Type: Article

References (34)

1. Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992; 76(1): 47-52.
2. De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996; 85(1): 73-81.
3. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002; 97(1): 3-11.
4. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol. 2004; 46(4): 220-229.
5. Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst. 2005; 21(8-9): 747-757.
6. Crom DB, Smith D, Xiong Z, et al. Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs. 2010; 42(6): 323-328.
7. Sughrue ME, Yang I, Kane AJ, et al. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011; 101(3): 463-476.
8. Muller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res. 2008; 69(4): 193-202.
9. Jung TY, Jung S, Moon KS, Kim IY, Kang SS, Kim JH. Endocrinological outcomes of pediatric craniopharyngiomas with anatomical pituitary stalk preservation: preliminary study. Pediatr Neurosurg. 2010; 46(3): 205-212.
10. Steno J, Bizik I, Steno A, Matejcik V. Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst. 2011; 27(1): 41-54.
11. Hukin J, Steinbok P, Lafay-Cousin L, et al. Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer. 2007; 109(10): 2124-2131.
12. Cavalheiro S, Di Rocco C, Valenzuela S, et al. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus. 2010; 28(4): E12.
13. Stripp DC, Maity A, Janss AJ, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys. 2004; 58(3): 714-720.
14. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007; 106(1 Suppl): 3-12.
15. Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J. Weight gain in craniopharyngioma - a model for hypothalamic obesity. J Pediatr Endocrinol Metab. 2006; 19(2): 121-127.
16. Muller HL, Gebhardt U, Teske C, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol. 2011; 165(1): 17-24.
17. World Health Organization. Growth reference 5-19 years. http://www.who.int/growthref/who2007-bmi-for-age/en/index.html. 2012. Accessed February 5, 2013.
18. Lafay-Cousin L, Bartels U, Raybaud C, et al. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg. 2007; 107(4 Suppl): 318-323.
19. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010; 28(4): E10.
20. Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg. 1985; 62(1): 120-127.
21. Jiang R, Liu Z, Zhu C. Preliminary exploration of the clinical effect of bleomycin on craniopharyngiomas. Stereotact Funct Neurosurg. 2002; 78(2): 84-94.
22. Park DH, Park JY, Kim JH, et al. Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Korean Med Sci. 2002; 17(2): 254-259.
23. Steinbok P, Hukin J. Intracystic treatments for craniopharyngioma. Neurosurg Focus. 2010; 28(4): E13.
24. Maimone D, Grimaldi LM, Incorpora G, et al. Intrathecal interferon in subacute sclerosing panencephalitis. Acta Neurol Scand. 1988; 78(3): 161-166.
25. Chamberlain MC. A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis. Cancer. 2002; 94(10): 2675-2680.
26. Cavalheiro S, Dastoli PA, Silva NS, Toledo S, Lederman H, da Silva MC. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst. 2005; 21(8-9): 719-724.
27. Ierardi DF, Fernandes MJ, Silva IR, et al. Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv Syst. 2007; 23(9): 1041-1046.
28. Bartels U, Laperriere N, Bouffet E, Drake J. Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne). 2012; 3: 39.
29. Elliott RE, Wisoff JH. Surgical management of giant pediatric craniopharyngiomas. J Neurosurg Pediatr. 2010; 6(5): 403-416.
30. Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys. 2002; 53(3): 533-542.
31. Elliott RE, Jane JA, Jr., Wisoff JH. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery. 2011; 69(3): 630-643.
32. Flitsch J, Muller HL, Burkhardt T. Surgical strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne). 2011; 2: 96.
33. Fernandez-Miranda JC, Gardner PA, Snyderman CH, et al. Craniopharyngioma: a pathologic, clinical, and surgical review. Head and Neck. 2012; 34(7): 1036-1044.
34. Obesity in Canada. Prevalence among children and youth. http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/chi-jeu-eng.php. Accessed February 5, 2013.